{'fraction_non_alphanumeric': 0.018258426966292134, 'fraction_numerical': 0.004213483146067416, 'mean_word_length': 5.254385964912281, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Treatment of Acute Herpes Zoster Pain and Postherpetic Neuralgia

With advancing age or immunocompromised states, the varicella zoster virus can reactivate, resulting in an eruption of acute herpes zoster (HZ), also known as shingles. More than 1 million Americans are diagnosed with acute HZ each year, and it is estimated that up to 20% of those who develop herpes zoster will subsequently develop postherpetic neuralgia (PHN). As the most common complication of HZ, PHN can cause significant suffering and reduced quality of life. Clinicians across all disciplines should be aware of the preventive measures for reducing the incidence of HZ and Treatment of Acute Herpes Zoster Pain and Postherpetic Neuralgia